| Literature DB >> 33116668 |
Fatma A El-Gohary1, Lina Jamil M Abdel-Hafez2, Amira I Zakaria3, Radwa Reda Shata3, Amin Tahoun4, Amany El-Mleeh5, Eman A Abo Elfadl6, Ehab Kotb Elmahallawy7,8.
Abstract
PURPOSE: The last few decades have witnessed a rapid and global increase in multidrug-resistant bacteria (MDR) emergence.Entities:
Keywords: AgNPs-H2O2; MBC; MDR pathogens; MIC; time-kill curve
Year: 2020 PMID: 33116668 PMCID: PMC7550212 DOI: 10.2147/IDR.S271261
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Antibiotics Used to Test Antimicrobial Susceptibility of Five Types of Bacteria
| Bacteria | Antimicrobials |
|---|---|
| Sulfamethoxazole-trimethoprim (25 µg), Chloramphenicol (30 µg), Ciprofloxacin (5 µg), Amoxicillin (25 µg), Norfloxacin (10 µg), Nalidixic acid (30 µg), Cefotaxime (30 µg), Cephalexin (30 µg) | |
| Rifampicin (5 µg), Oxacillin (1 µg), Tetracycline (30 µg), Amoxicillin (10 µg), Gentamycin (10 µg), Cefotaxime (30 µg), Cefepime (30 µg), Sulfamethoxazole-trimethoprim (25 µg), Carbenicillin (30 µg), Ampicillin (10 µg), Chloramphenicol (30 µg) | |
| Neomycin (30 µg), Kanamycin (30 µg), Tetracycline (30 µg), Nalidixic acid (30 µg), Streptomycin (10 µg), Gentamycin (10 µg), Chloramphenicol (30 µg), Ampicillin (10 µg) | |
| Ciprofloxacin (5 µg), Neomycin (30 µg), Norfloxacin (10 µg), Streptomycin (10 µg), Kanamycin (30 µg), Levofloxacin (5 µg), Carbapenem (100 µg), Cephalexin (30 µg), Cefepime (30 µg) | |
| Chloramphenicol (30 µg), Ampicillin (10 µg), Tetracycline (30 µg), Streptomycin (10 µg), Cefotaxime (30 µg), Carbenicillin (30 µg), Erythromycin (15 µg), Cephalexin (30 µg) |
Frequency Distribution of Bacterial Species Recovered from Dairy Farms and Slaughterhouse
| Sampling Site | Sampling Source | Prevalence of Bacterial Isolates – Number (%) | ||||
|---|---|---|---|---|---|---|
| Dairy farms | BTM | 12 (30) | 8 (20) | 8 (20) | 2 (5) | 10 (25) |
| MU | 10 (25) | 8 (20) | 14 (35) | 4 (10) | 4 (10) | |
| WHSs | 6 (15) | 10 (25) | 10 (25) | 8 (20) | 6 (15) | |
| Total | 23.3 | 21.7 | 26.7 | 11.7 | 16.7 | |
| Beef slaughterhouse | Carcass | 6 (30) | 6 (30) | 6 (30) | 2 (10) | 0 |
| KSs | 8 (40) | 4 (20) | 2 (10) | 4 (20) | 2 (10) | |
| WSs | 2 (10) | 8 (40) | 6 (30) | 4 (20) | 0 | |
| WHSs | 8 (40) | 2 (10) | 4 (20) | 4 (20) | 2 (10) | |
| Total | 30 | 25 | 22.5 | 17.5 | 5 | |
Notes: Number of samples; 120/dairy farm samples, 80/slaughterhouse samples.
Abbreviations: BTM, bulk tank milk; MU, milking utensils; KSs, knives’ swabs; WSs, wall swabs; WHSs, workers’ hands swabs.
Multidrug Resistance Patterns (MDR) of Recovered Bacterial Species (N=40) from Dairy Farms and a Beef Slaughterhouse
| Bacterial Species | % of Resistant Dairy Farm Isolates | % of Resistant Beef Abattoir Isolates | MDR Pattern* | MAR Index |
|---|---|---|---|---|
| 35.7 | 25 | E, AM, TE, S | 0.5 | |
| 46.2 | 20 | RA, CTX, TE, CN, C | 0.45 | |
| 25 | 44.4 | SXT, C, NOR, AM, CIP | 0.63 | |
| 28.6 | 85.7 | CIP, NOR, S, LEV | 0.44 | |
| 70 | 50 | N, K, TE, C, NA, AM, CN | 0.88 |
Notes: *Erythromycin (E; 15 µg), Rifampicin (RA; 5 µg), Chloramphenicol (C; 30 µg), Norfloxacin (NOR; 10 µg), Levofloxacin (LEV; 5 µg), Neomycin (N; 30 µg), Nalidixic acid (NA; 30 µg), Ciprofloxacin (CIP; 5 µg), Tetracycline (TE; 5 µg), Amoxicillin (AM; 25 µg), Cefotaxime (CXT; 30 µg), Kanamycin (K; 30 µg), Trimethoprim/sulphamethoxazole (SXT; 25 µg), Gentamycin (CN; 10 µg), Streptomycin (S; 10 µg).
Abbreviation: MAR, multiple antibiotic resistance index.
Figure 1Characterization of AgNPs-H2O2 product, TEM micrographs and size distribution for silver (scale bar: 100 nm), micrographs displays AgNPs-H2O2 with sizes ranging from (30.17–67.92 nm) based on TEM images.
Figure 2Zeta-potential of AgNPs-H2O2 product, −0.192 mV surface charge – good quality nanoparticles.
MIC, MBC Values, and MBC/MIC Ratio of Commercial AgNPs-H2O2 Product Against MDR Bacterial Species
| MDR Bacteria | Concentration (µg/mL) | MBC/MIC Ratio | Degree of Agreement Between MIC and MBC Tests %* | ||
|---|---|---|---|---|---|
| MIC | MBC | ||||
| 2 | <0.0001 | 82 | |||
| 12.5 | 50 | 4 | <0.0001 | 30 | |
| 3.125 | 6.25 | 2 | <0.0001 | 83 | |
| 6.25 | 50 | 8 | <0.0001 | 30 | |
| 25 | 50 | 2 | <0.0001 | 80 | |
Note: *Kappa test association.
Figure 3Time-kill assays of AgNPs-H2O2 against multidrug-resistant bacteria. (A) L. monocytogenes, (B) P. aeruginosa, (C) S. typhimurium, (D) E. coli O157:H7, (E) K. pneumoniae, and (F) comparison of time-kill assay of AgNPs-H2O2 against all tested MDR bacteria. The measurements were made at 0, 2, 4, 6, 8, 12, and 24 hours post-treatment, viability of microorganisms expressed by CFU/mL, data points represented by mean±SEM for triplicates of each experiment.